Background: Original apical hypertrophic cardiomyopathy was characterized by left ventricular hypertrophy confined to the apex below the papillary muscle level. In contrast, apical hypertrophic cardiomyopathy in Western countries often includes hypertrophy extending to the midventricular septum. Recognizing these phenotypic differences is essential as they may influence the clinical prognosis. The aim of this study was to delineate the clinical and genetic disparities between the pure-apical form, according to the original definition, and the distal-dominant form, in which hypertrophy extends to the ventricular septum without basal septal hypertrophy.
Methods: A retrospective analysis was conducted for 111 consecutive patients with apical hypertrophic cardiomyopathy with assessment of hypertrophic cardiomyopathy-related adverse events including hypertrophic cardiomyopathy-related death, heart failure admission, embolic stroke admission, and sustained ventricular tachycardia with hemodynamic instability or appropriate implantable cardioverter-defibrillator discharge. Genetic testing for hypertrophic cardiomyopathy-associated genes was performed in 72 patients.
Results: Among the patients, 60 were classified as pure-apical form, and 51 were classified as distal-dominant form. The median age at diagnosis was 63 years, with a predominance of men in both groups. Over a follow-up period of 11.0 years, the incidence of hypertrophic cardiomyopathy-related adverse events was significantly higher in the distal-dominant group than in the pure-apical group (log-rank, <0.001). The detection rate of pathogenic or likely pathogenic variants was also significantly higher in the distal-dominant group than in the pure-apical group (26% versus 3%; =0.005).
Conclusions: Distinct clinical and genetic profiles of the 2 apical hypertrophic cardiomyopathy phenotypes warrant their recognition and differentiation in clinical practice due to distinct prognoses and genetic backgrounds.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1161/JAHA.124.038208 | DOI Listing |
J Am Heart Assoc
March 2025
Department of Cardiology and Geriatrics, Kochi Medical School Kochi University Kochi Japan.
Background: Original apical hypertrophic cardiomyopathy was characterized by left ventricular hypertrophy confined to the apex below the papillary muscle level. In contrast, apical hypertrophic cardiomyopathy in Western countries often includes hypertrophy extending to the midventricular septum. Recognizing these phenotypic differences is essential as they may influence the clinical prognosis.
View Article and Find Full Text PDFJACC Case Rep
March 2025
Cardiology Department, Fundación Cardioinfantil-LaCardio, Bogotá, Colombia.
Endomyocardial fibrosis (EMF) is the most common cause of restrictive cardiomyopathy in Africa and South America. We present a case of a 55-year-old man who experienced an anterior myocardial infarction due to thrombotic occlusion of the left anterior descending artery. Multimodality imaging revealed left ventricular (LV) apical obliteration, apical thrombus, and subendocardial fibrosis, without significant systolic dysfunction, consistent with EMF.
View Article and Find Full Text PDFBackground: The efficacy of artificial intelligence (AI)-enhanced electrocardiography (ECG) for detecting hypertrophic cardiomyopathy (HCM) and its dilated phase (dHCM) has been developed, though specific ECG characteristics associated with these conditions remain insufficiently characterized.
Methods: This retrospective study included 19,170 patients, with 140 HCM or dHCM cases, from the Shinken Database (2010-2017). The 140 cases (HCM-total) were categorized into basal-only HCM (HCM-basal, = 75), apical involvement (HCM-apical, = 46), and dHCM ( = 19).
Heart
March 2025
Department of Cardiology and Geriatrics, Kochi University, Kochi, Japan.
Background: The Japanese Hypertrophic Cardiomyopathy Registry Study was designed to provide comprehensive, real-world insights into the clinical characteristics and management of hypertrophic cardiomyopathy (HCM) in Japan.
Methods: This multicentre, prospective study enrolled consecutive patients with HCM from 24 referral hospitals across Japan starting in 2016. The baseline characteristics of 1485 patients enrolled by December 2019 are presented in this analysis.
J Thorac Imaging
February 2025
Department of Radiology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University.
Purpose: To investigate the left ventricular (LV) trabecular complexity and evaluate its relationship with LV cardiac function and especially myocardial strain in patients with hypertrophic cardiomyopathy (HCM).
Materials And Methods: A total of 100 patients were retrospectively recruited in the study, including 50 obstructive hypertrophic cardiomyopathy (HOCM) and 50 nonobstructive HCM (NOHCM). Fifty age-matched and sex-matched healthy participants were also enrolled.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!